KEGG: mcf:102129936
UniGene: Mfa.2961
Macaca fascicularis, also known as long-tailed macaque or cynomolgus monkey, is one of the most important nonhuman primate animal models in basic and applied biomedical research. Its genome has been sequenced using whole-genome shotgun sequencing approaches, revealing approximately 99.21% DNA sequence identity with Macaca mulatta (rhesus macaque) and 92.83% identity with the human genome .
The importance of M. fascicularis stems from its close evolutionary relationship with humans, with the split between M. fascicularis and M. mulatta occurring approximately 2.8 million years ago . This genetic similarity makes it an invaluable model for:
Drug safety assessment and pharmacological studies
Disease modeling and progression monitoring
Toxicological evaluation
Immunological and vaccine research
The genome sequencing has enabled high-resolution genotyping and microarray-based gene expression profiling for animal stratification, allowing researchers to use well-characterized animals for more precise and reproducible studies .
The term "uncharacterized protein" indicates that while the protein's sequence is known, its biological function, three-dimensional structure, and role in cellular processes remain experimentally undetermined. The C7orf45 homolog in M. fascicularis (UniProt accession: Q4R309) shares sequence similarity with the human C7orf45 (Chromosome 7 Open Reading Frame 45) protein, suggesting evolutionary conservation, but its specific functions have not been experimentally validated .
Homology refers to similarity due to shared ancestry. While the protein sequence is known (244 amino acids for the full-length protein), and it has been successfully expressed as a recombinant protein, the biological significance and functional properties require further investigation through various experimental approaches .
For optimal stability and activity of the Recombinant Macaca fascicularis Uncharacterized protein C7orf45 homolog (QtsA-20413), the following storage and handling conditions are recommended:
Storage buffer: Tris-based buffer with 50% glycerol, optimized specifically for this protein
Long-term storage: Store at -20°C; for extended storage, -80°C is recommended
Freeze-thaw cycles: Repeated freezing and thawing is not recommended
When designing experiments, it's advisable to:
Prepare small working aliquots to minimize freeze-thaw cycles
Equilibrate the protein to room temperature before opening tubes to prevent condensation
Consider buffer compatibility when introducing the protein into experimental systems
Validate protein stability under your specific experimental conditions
The population structure of M. fascicularis has significant implications for research involving proteins derived from this species:
M. fascicularis exhibits complex population structure with distinct genetic differences between subspecies and geographical populations:
M. f. aurea is genetically distinct from both forms of M. f. fascicularis and M. mulatta
Hybridization between M. f. aurea and M. f. fascicularis occurs in two directions: south-north (8°25' to 15°56') and west-east (98°28' to 99°02')
Low levels of M. mulatta introgression have been detected in some M. f. aurea populations
These population differences can affect protein studies in several ways:
Potential amino acid sequence variations between populations
Differences in post-translational modifications
Varied expression levels across populations
For more controlled studies, researchers should consider:
Using samples from the Mauritian population, which has limited genetic variability
Documenting the precise geographical origin of the M. fascicularis samples used
Including appropriate population controls when comparing results across studies
Functional characterization of the C7orf45 homolog requires a multi-faceted approach combining computational predictions with experimental validation:
Computational Analysis:
Sequence homology and phylogenetic analysis to identify conserved domains
Structural prediction using tools like AlphaFold or I-TASSER
Identification of potential functional motifs, post-translational modification sites, and interaction domains
Experimental Characterization Strategy:
| Approach | Methodology | Expected Outcome |
|---|---|---|
| Expression Analysis | RNA-seq, qPCR across tissues | Tissue-specific expression patterns |
| Subcellular Localization | Fluorescent tagging, subcellular fractionation | Cellular compartment identification |
| Interaction Partners | Co-immunoprecipitation, proximity labeling (BioID), yeast two-hybrid | Identification of protein complexes |
| Loss-of-Function | CRISPR-Cas9 knockout, RNAi | Phenotypic consequences |
| Gain-of-Function | Overexpression studies | Functional effects |
| Biochemical Assays | Based on predicted function (enzymatic, binding) | Specific activity characterization |
A systematic investigation would typically begin with expression and localization studies to provide context for more specific functional assays. The combination of these approaches would gradually build a comprehensive understanding of the protein's biological role.
Comparative genomics provides powerful approaches to predict functions of uncharacterized proteins like the C7orf45 homolog:
Cross-Species Sequence Analysis:
Identify orthologs across species, particularly in well-studied organisms
Analyze sequence conservation patterns to identify functionally important regions
Examine evolution of the gene family to understand functional diversification
The high genome sequence identity between M. fascicularis and other primates (99.21% with M. mulatta, 92.83% with humans) facilitates robust comparative analysis .
Co-Evolution Analysis:
Identify genes that show similar evolutionary patterns (phylogenetic profiling)
Examine syntenic regions across genomes to identify functionally related gene clusters
Analyze co-evolution of residues to predict structural interactions
Expression Context Analysis:
Compare expression patterns of orthologs across species
Identify co-expressed genes in different organisms
Examine expression changes in developmental or disease contexts
Integration with Functional Data:
Map known functions of orthologs to the uncharacterized protein
Utilize phenotypic data from model organism databases
Integrate with protein-protein interaction networks
These approaches can generate testable hypotheses about the potential functions of the C7orf45 homolog, guiding experimental design for validation studies.
Developing specific antibodies against the C7orf45 homolog requires careful epitope selection and validation:
Epitope Selection Strategy:
Identify regions unique to M. fascicularis C7orf45 homolog to minimize cross-reactivity
Select epitopes with high predicted antigenicity, surface accessibility, and structural stability
Consider both N-terminal and C-terminal regions, which are often accessible
Recommended Epitope Regions Based on Sequence Analysis:
| Region | Sequence Position | Selection Rationale |
|---|---|---|
| Region 1 | 20-40 | High predicted antigenicity, species-specific |
| Region 2 | 110-130 | Surface accessibility, unique sequence |
| Region 3 | 220-244 (C-terminus) | Terminal accessibility, distinctive sequence |
Antibody Production Approaches:
Peptide antibodies: Synthesize 15-20 amino acid peptides from selected regions
Recombinant protein antibodies: Express full-length or domain fragments of the protein
Consider both polyclonal (broader epitope recognition) and monoclonal (higher specificity) approaches
Validation Strategy:
Test against recombinant protein using ELISA and Western blotting
Confirm specificity using tissue samples from M. fascicularis
Check for cross-reactivity with human and M. mulatta homologs
Validate for specific applications (Western blot, immunoprecipitation, immunohistochemistry)
Properly validated antibodies are essential tools for investigating protein expression, localization, interactions, and post-translational modifications.
The complex population structure of M. fascicularis necessitates careful experimental design to account for genetic variations:
Sample Selection and Documentation:
Document the precise geographical origin of biological samples
Consider using Mauritius-origin M. fascicularis, which has limited genetic variability
Be aware of potential hybrid populations, particularly between M. f. aurea and M. f. fascicularis
Genotyping Approaches:
Sequence the C7orf45 homolog gene in study subjects to identify variations
Use available M. fascicularis genomic resources, including the ~2.1 million identified SNPs
Consider broader genotyping to place samples within population structure context
Experimental Design Considerations:
| Experimental Approach | Recommended Controls |
|---|---|
| Expression Studies | Include samples from multiple populations; normalize to population-specific reference genes |
| Functional Assays | Compare effects across different genetic backgrounds |
| Protein-Protein Interactions | Verify interactions with proteins from matched genetic backgrounds |
| Antibody Studies | Validate specificity across different M. fascicularis populations |
Data Analysis Strategy:
Stratify results based on genetic background
Include genetic variations as covariates in statistical analyses
Validate key findings across different genetic backgrounds
This approach improves reproducibility and translational relevance while acknowledging the natural genetic diversity present in M. fascicularis populations.
Investigating structure-function relationships for the C7orf45 homolog requires integrating computational prediction with experimental validation:
Structural Prediction and Analysis:
Generate 3D structural models using methods like AlphaFold, I-TASSER, or Rosetta
Identify potential functional sites (binding pockets, catalytic residues)
Map evolutionary conservation onto structural models to highlight functionally important regions
Predict protein dynamics through molecular dynamics simulations
Structure-Guided Experimental Approaches:
| Approach | Methodology | Functional Insights |
|---|---|---|
| Site-Directed Mutagenesis | Mutate predicted functional residues | Validate importance of specific residues |
| Domain Truncation | Express individual domains | Identify functionally independent modules |
| Protein Engineering | Create chimeric proteins | Map domain-specific functions |
| Chemical Modification | Modify specific residues | Identify catalytic or binding residues |
| Structural Biology | X-ray crystallography, Cryo-EM | High-resolution structural information |
Integrative Analysis:
Correlate structural features with binding or enzymatic properties
Map interaction interfaces based on structural models and experimental data
Use structure to guide the design of inhibitors or activators
This systematic approach bridges computational prediction and experimental validation to establish mechanistic understanding of how protein structure determines function.
Mass spectrometry (MS) offers powerful approaches for characterizing post-translational modifications (PTMs) of the C7orf45 homolog:
Sample Preparation Strategy:
Express and purify recombinant protein under native conditions
Isolate endogenous protein from relevant M. fascicularis tissues
Prepare samples with modification-specific enrichment methods
MS-Based Analytical Approaches:
| Approach | Methodology | PTM Information |
|---|---|---|
| Bottom-up Proteomics | Enzymatic digestion followed by LC-MS/MS | Identification and localization of PTMs |
| Top-down Proteomics | Analysis of intact protein | Combinatorial PTM patterns |
| Targeted MS | Selected/Multiple Reaction Monitoring (SRM/MRM) | Quantification of specific modified peptides |
| PTM Enrichment | Phosphopeptide enrichment, ubiquitin remnant antibodies | Enhanced detection of specific modifications |
Data Analysis and Validation:
Search MS data against databases with variable modifications
Validate PTM sites with site-directed mutagenesis
Quantify PTM stoichiometry under different conditions
Correlate PTMs with protein function or localization
Biological Context Integration:
Compare PTM patterns across tissues and developmental stages
Analyze PTMs in response to cellular signaling
Correlate PTMs with protein-protein interactions
This comprehensive MS-based approach can reveal dynamic PTM patterns that regulate the function, localization, and interactions of the C7orf45 homolog.
Understanding the tissue-specific expression profile of the C7orf45 homolog requires a multi-modal approach:
Transcriptome Analysis:
RNA-seq analysis across multiple M. fascicularis tissues
Quantitative RT-PCR with tissue-specific samples and appropriate reference genes
In situ hybridization to localize expression within complex tissues
Protein-Level Analysis:
Western blotting using validated antibodies
Immunohistochemistry for spatial resolution within tissues
Mass spectrometry-based proteomics for quantitative comparison
Experimental Design Considerations:
| Consideration | Recommendation |
|---|---|
| Tissue Selection | Include major organs (brain, liver, kidney, etc.) and specialized tissues |
| Developmental Stages | Compare expression across different ages |
| Sex Differences | Analyze samples from both male and female animals |
| Population Variation | Include samples from different genetic backgrounds |
Data Integration Framework:
Correlate mRNA and protein expression levels
Compare with expression patterns in related species
Analyze expression in relation to tissue-specific functions
A comprehensive tissue expression profile would provide valuable insights into potential tissue-specific functions of the C7orf45 homolog and guide further functional studies in the most relevant biological contexts.
Designing effective gene silencing experiments for the C7orf45 homolog requires careful consideration of methodology, controls, and phenotypic analysis:
Silencing Methodology Selection:
| Approach | Advantages | Considerations |
|---|---|---|
| CRISPR-Cas9 Knockout | Complete gene elimination | Potential compensation mechanisms |
| siRNA/shRNA | Transient and tunable silencing | Off-target effects, incomplete knockdown |
| Antisense Oligonucleotides | High specificity | Delivery challenges, variable efficiency |
| CRISPRi | Transcriptional repression without editing | Requires promoter characterization |
Target Design Strategy:
Design multiple guide RNAs or siRNAs targeting different regions of the gene
Verify target specificity through bioinformatic analysis
Consider functional domains identified through computational analysis
Design constructs that allow for inducible or tissue-specific silencing
Essential Controls:
Non-targeting control constructs
Rescue experiments with wild-type C7orf45 homolog
Targeting of known genes with well-characterized phenotypes
Verification of knockdown efficiency at mRNA and protein levels
Phenotypic Analysis Framework:
Begin with broad phenotypic assessment (viability, morphology, proliferation)
Progress to targeted assays based on predicted function
Analyze effects at cellular, molecular, and biochemical levels
Consider temporal dynamics of phenotypic changes
Validation Strategy:
Confirm phenotypes with multiple independent silencing constructs
Verify specificity through rescue experiments
Correlate phenotype severity with knockdown efficiency
Compare results with orthogonal approaches (e.g., protein inhibition)
This systematic approach maximizes the likelihood of identifying specific and reproducible phenotypes that provide insights into the function of the C7orf45 homolog.